The potential new indication for CSU comes as Regeneron and Sanofi continue ... the FDA approved Dupixent for chronicobstructivepulmonarydisease (COPD), marking its sixth indication and ...
SIOUX CITY (KTIV) - The World Health Organization says chronicobstructivepulmonarydisease (COPD) is the third leading cause of death worldwide, causing 3.23 million deaths in 2019. COPD is ...